Literature DB >> 10448541

Time-to-event analysis, or who gets better sooner? An emerging concept in headache study methodology.

C Allen1, K Jiang, W Malbecq, P J Goadsby.   

Abstract

Survival analysis, or, more generally, time-to-event analysis, is of interest when the data represent the time to a defined event. While well established in oncology, it has not been widely applied to migraine research, possibly because the data are usually collected intermittently, rather than continuously, and because of the awkwardness of interpreting treatment effect in survival terms. However, it represents an interesting approach for the analysis of time-to-headache relief, which addresses the clinically relevant question of who gets better sooner. The analysis uses data from all time-points to define the likelihood of headache relief following treatment throughout the entire assessment period. These data can then be used to quantify and test the difference between two therapies.

Entities:  

Mesh:

Year:  1999        PMID: 10448541     DOI: 10.1046/j.1468-2982.1999.019006552.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  4 in total

1.  Modelling the anti-migraine effects of BIBN 4096 BS: a new calcitonin gene-related peptide receptor antagonist.

Authors:  Iñaki F Trocóniz; Jan-Markus Wolters; Christiane Tillmann; Hans G Schaefer; Willy Roth
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Assessing the efficacy of drugs for the acute treatment of migraine: issues in clinical trial design.

Authors:  Nabih M Ramadan
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

Authors:  B Bodini; M Battaglini; N De Stefano; Z Khaleeli; F Barkhof; D Chard; M Filippi; X Montalban; C Polman; M Rovaris; A Rovira; R Samson; D Miller; A Thompson; O Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-07-13       Impact factor: 10.154

4.  Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.

Authors:  Hans-Christoph Diener; Cristina Tassorelli; David W Dodick; Stephen D Silberstein; Richard B Lipton; Messoud Ashina; Werner J Becker; Michel D Ferrari; Peter J Goadsby; Patricia Pozo-Rosich; Shuu-Jiun Wang; Jay Mandrekar
Journal:  Cephalalgia       Date:  2019-02-26       Impact factor: 6.292

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.